{"id":"W2101725260","doi":"10.1182/blood-2014-03-560557","title":"Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cytarabine; Hazard ratio; Internal medicine; Adverse effect; Myeloid leukemia; Confidence interval; Surgery; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001290296,0.0001859778,0.0008989547,0.0002286395,0.0000399815,0.00001194304,0.0001152753,0.0001303346,0.00006013877],"category_scores_gemma":[0.001169696,0.0001115569,0.0001087829,0.00029708,0.0001261898,0.000121781,0.00002177856,0.0002388525,0.000005527453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007167898,"about_ca_system_score_gemma":0.0003265843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002227769,"about_ca_topic_score_gemma":0.00004970959,"domain_scores_codex":[0.998211,0.0002127695,0.0004914525,0.0003015784,0.000436955,0.0003462083],"domain_scores_gemma":[0.9986404,0.0004096905,0.0001861148,0.0003548268,0.0002881995,0.0001207783],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9745785,0.005204177,0.003174315,0.000117246,0.0001891851,0.000004272568,0.0002649832,0.000003209224,0.01109057,0.00001304485,0.0001357669,0.005224704],"study_design_scores_gemma":[0.9099881,0.009139423,0.000576076,0.0001248856,0.0001477304,0.00000639324,0.00003392926,0.0009096797,0.07860799,0.00001646971,0.0003268542,0.0001224428],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938821,0.00002548489,0.0003073082,0.0002143856,0.00009892357,0.005262757,0.00001686934,0.00002794015,0.0001642209],"genre_scores_gemma":[0.9969323,0.00005668552,0.001091482,0.0001418274,0.0002942497,0.0005711254,0.0000880773,0.0000460073,0.0007782701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06751742,"threshold_uncertainty_score":0.4549158,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03015493291202409,"score_gpt":0.3241393303237978,"score_spread":0.2939843974117737,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}